Q3 sales at Johnson Matthey's Fine Chemicals Division improved 10% over last year. The company said sales of APIs remained good, particularly in North America, and the performance of its Pharmaceutical Services business continued to improve.
Johnson Matthey
Wednesday, 2 February 2011
Fine chems grow for Johnson Matthey in Q3
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment